Prader-Willi Syndrome: Clinical Trials

4 trials for Prader-Willi Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Prader-Willi Syndrome: new trials by email Literature Review of Prader-Willi Syndrome trials Research Report on Prader-Willi Syndrome

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
Guanfacine Extended Release, Placebo - Prader-Willi Syndrome, Aggression
Phase 4CompletedMaimonides Medical Center152020-12-172024-08-19
GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition
Growth hormone, Placebo - Prader-Willi Syndrome
Phase 4CompletedCorporacion Parc Tauli302017-06-192021-01-27
Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome
Medical Air vs Oxygen - Sleep Apnea, Central, Prader-Willi Syndrome
Phase 4CompletedThe Hospital for Sick Children92016-09-012025-06-08
Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?
Growth hormone (Genotonorm® or Omnitrope®), DEXA, blood tests, H.G.P.O, osseous age., biopsy - Prader-Willi Syndrome, Growth Hormone Deficiency
Phase 4CompletedUniversity Hospital, Toulouse1112009-01-012021-09-24

Narrower conditions

Abnormalities, Multiple (1)  ·  Aggression (1)  ·  Behavioral Symptoms (1)  ·  Chromosome Disorders (1)  ·  Congenital Abnormalities (1)  ·  Dwarfism, Pituitary (1)  ·  Excoriation Disorder (1)  ·  Genetic Diseases, Inborn (1)  ·  Intellectual Disability (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Nutrition Disorders (1)  ·  Obesity (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Imprinting Disorders (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Overweight (4)  ·  Abnormalities, Multiple (3)  ·  Chromosome Disorders (3)  ·  Congenital Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Intellectual Disability (3)  ·  Nervous System Diseases (3)  ·  Neurobehavioral Manifestations (3)  ·  Neurologic Manifestations (3)  ·  Nutrition Disorders (3)  ·  Obesity (3)  ·  Overnutrition (3)

Interventions

Growth Hormone (2)  ·  Absorptiometry, Photon (1)  ·  Biopsy (1)  ·  Guanfacine (1)  ·  Hematologic Tests (1)  ·  Human Growth Hormone (1)

Sponsors

Corporacion Parc Tauli (1)  ·  Maimonides Medical Center (1)  ·  The Hospital for Sick Children (1)  ·  University Hospital, Toulouse (1)

Countries

Canada (1)  ·  France (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Deepan Singh, MD (1)  ·  Olga Gimenez-Palop, MD, PhD (1)  ·  Reshma Amin, MD (1)

Results publications

PMID 24406482, PMID 24916642, PMID 34040195, PMID 38561465

NIH funding

2017 (1)